Unique Sjögren’s syndrome patient subsets defined by molecular features

OBJECTIVE: To address heterogeneity complicating primary SS (pSS) clinical trials, research and care by characterizing and clustering patients by their molecular phenotypes. METHODS: pSS patients met American–European Consensus Group classification criteria and had at least one systemic manifestatio...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Rheumatology (Oxford)
Asıl Yazarlar: James, Judith A, Guthridge, Joel M, Chen, Hua, Lu, Rufei, Bourn, Rebecka L, Bean, Krista, Munroe, Melissa E, Smith, Miles, Chakravarty, Eliza, Baer, Alan N, Noaiseh, Ghaith, Parke, Ann, Boyle, Karen, Keyes-Elstein, Lynette, Coca, Andreea, Utset, Tammy, Genovese, Mark C, Pascual, Virginia, Utz, Paul J, Holers, V. Michael, Deane, Kevin D, Sivils, Kathy L, Aberle, Teresa, Wallace, Daniel J, McNamara, James, Franchimont, Nathalie, St. Clair, E. William
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Oxford University Press 2020
Konular:
Clinical Science
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7188221/
https://ncbi.nlm.nih.gov/pubmed/31497844
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/rheumatology/kez335
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller